Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
7,912,306
-
Shares change
-
+6,166,612
-
Total reported value, excl. options
-
$135,154,730
-
Value change
-
+$104,953,779
-
Number of buys
-
24
-
Price
-
$17.3
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2018
26 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q2 2018.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,912,306 shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (1,572,910 shares), FMR LLC (1,502,576 shares), EcoR1 Capital, LLC (1,272,198 shares), COWEN INC. (1,052,422 shares), Omega Fund Management, LLC (693,272 shares), VICTORY CAPITAL MANAGEMENT INC (448,670 shares), FRANKLIN RESOURCES INC (350,000 shares), SPHERA FUNDS MANAGEMENT LTD. (227,900 shares), Marshall Wace North America L.P. (110,578 shares), and ACUTA CAPITAL PARTNERS, LLC (100,000 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.